Royal Bank Of Canada Pulmonx Corp Call Options Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LUNG
# of Institutions
130Shares Held
31.2MCall Options Held
300Put Options Held
204K-
Primecap Management CO Pasadena, CA5.51MShares$38.4 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.07MShares$21.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$18.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$15.9 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.53MShares$10.7 Million0.26% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $260M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...